GO:0034237 protein kinase A regulatory subunit binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034237 describes the molecular function of binding to one or both regulatory subunits of protein kinase A (PKA), a central cAMP-dependent kinase.
• PKA regulatory subunits (PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B) are the primary binding partners and serve as anchors, inhibitors, and cAMP sensors [3,5].
• The interaction is dynamic: cAMP binding to the regulatory subunit releases the catalytic subunit, enabling phosphorylation of downstream targets.
• A-kinase anchoring proteins (AKAPs) such as talin can mechanically gate PKA regulatory subunit binding, linking force to signaling.
• Dysregulation of PKA regulatory subunit binding is implicated in sleep-wake disorders, immune dysfunction, and pathogen morphogenesis [2,8,1].
• CRISPR knockout, point mutation, and knock-in models are essential to dissect isoform-specific functions of PKA regulatory subunit binding [5,6].
Description
Protein kinase A (PKA) is a ubiquitous serine/threonine kinase that transduces cAMP signals into cellular responses. The PKA holoenzyme is a tetramer composed of two catalytic subunits and two regulatory subunits. The molecular function defined by GO:0034237, protein kinase A regulatory subunit binding, refers to the binding of a protein to one or both of these regulatory subunits. This interaction is fundamental to PKA biology because the regulatory subunits serve as the primary sensors of cAMP and as inhibitors of the catalytic subunits in the absence of cAMP. Researchers study this binding event to understand how PKA is localized, how its activity is switched on and off, and how mutations in regulatory subunits contribute to disease [3,5]. The regulatory subunits are not passive inhibitors; they are docking platforms for AKAPs, phosphatases, and other signaling proteins, making GO:0034237 a hub for signal integration. In this article, we synthesize authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0034237, covering its mechanism, key genes, disease relevance, and experimental models.
protein kinase A regulatory subunit binding At A Glance
| GO ID | GO:0034237 |
|---|---|
| GO term | protein kinase A regulatory subunit binding |
| Ontology | molecular_function |
| Synonym | PKA regulatory subunit binding; protein kinase A anchoring activity |
| Definition | Binding to one or both of the regulatory subunits of protein kinase A. |
| Major function | Anchoring, inhibiting, or modulating PKA catalytic activity and subcellular localization. |
| Key binding partners | PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B, AKAPs (e.g., talin), CREB [3,4,8]. |
| Related disease | Sleep-wake disorders, immune dysregulation, Leishmania morphogenesis defects [1,2,8]. |
What Is GO:0034237?
GO:0034237 is a molecular function term defined as binding to one or both of the regulatory subunits of protein kinase A. In other words, it describes the physical interaction between a protein and the regulatory subunit (type I or type II) of PKA, often through a docking motif such as the amphipathic helix found in AKAPs. This binding can anchor PKA to specific subcellular locations, modulate its activity, or compete with cAMP for the regulatory subunit surface [3,4].
Why Is protein kinase A regulatory subunit binding Important in Cell Biology?
GO:0034237 is important because it governs the spatial and temporal control of PKA, one of the most versatile kinases in eukaryotes. By binding to regulatory subunits, AKAPs and other proteins ensure that PKA phosphorylates the right substrates at the right time, influencing processes as diverse as sleep, immune activation, and pathogen development [2,4,1]. Mutations that alter this binding can lead to disease, making it a target for mechanistic studies and therapeutic intervention [5,8].
• Controls PKA localization and substrate specificity through AKAP-mediated anchoring.
• Regulates sleep-wake cycles via postsynaptic competition between calcineurin and PKA.
• Modulates CREB transcriptional activity in activated T cells through PRKAR2B binding.
• Essential for morphogenesis of the human pathogen Leishmania.
• Isoform-specific N3A motifs in PRKAR1B affect PKA regulation and may contribute to disease.
• Provides a mechanism for mechanical force sensing at focal adhesions via talin.
• Serves as a paradigm for understanding cAMP signaling specificity.
• Offers targets for CRISPR-based functional genomics in cancer and immunology.
• Links to neurological disorders through sleep and synaptic signaling.
• Enables high-throughput screening for modulators of PKA anchoring.
Molecular Mechanism of protein kinase A regulatory subunit binding
cAMP-dependent release of catalytic subunits
In simple terms: When cAMP binds to the regulatory subunit, it changes shape and lets go of the catalytic subunit, which then becomes active.
The PKA holoenzyme is inactive until cAMP binds to the regulatory subunits. Each regulatory subunit contains two cAMP-binding domains; cooperative binding of cAMP induces a conformational change that releases the catalytic subunits, allowing them to phosphorylate target proteins. This mechanism is conserved across isoforms, although the affinity and kinetics vary.
AKAP-mediated anchoring and subcellular targeting
In simple terms: Anchor proteins grab the regulatory subunit and pull PKA to specific places in the cell.
A-kinase anchoring proteins (AKAPs) bind to the dimerization/docking (D/D) domain of regulatory subunits through an amphipathic helix. This interaction tethers PKA to organelles, membranes, and cytoskeletal structures, ensuring localized signaling. Talin, a focal adhesion protein, acts as a mechanically gated AKAP, linking force to PKA regulatory subunit binding.
Isoform-specific regulation by N3A motifs
In simple terms: Different versions of the regulatory subunit have small sequence changes that alter how they work.
The N3A motif in PRKAR1B variants influences PKA regulation, affecting cAMP sensitivity and catalytic subunit release. Functional divergence among PRKAR1B variants highlights the importance of these motifs in fine-tuning PKA signaling.
Competition with phosphatases and other binding partners
In simple terms: Other proteins can compete with PKA for binding sites, tuning the signal.
At postsynaptic sites, calcineurin competes with PKA for binding to regulatory subunits, thereby regulating sleep-wake cycles. This competition determines the phosphorylation state of downstream targets and affects neuronal excitability.
Direct modulation of transcription factors
In simple terms: The regulatory subunit can directly interact with transcription factors like CREB to suppress their activity.
PRKAR2B directly interacts with and suppresses CREB transcriptional activity in activated T cells, demonstrating a non-canonical role for the regulatory subunit independent of catalytic subunit release.
Key Genes Involved in GO:0034237 protein kinase A regulatory subunit binding
The following genes encode proteins that bind to or are regulatory subunits of PKA, directly relevant to GO:0034237.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRKAR1A | Type I regulatory subunit alpha; binds cAMP and catalytic subunits | Mutations cause Carney complex; model for PKA signaling |
| PRKAR1B | Type I regulatory subunit beta; N3A motif variants affect regulation | Isoform-specific functions in neurons |
| PRKAR2A | Type II regulatory subunit alpha; anchors to AKAPs | Localized PKA signaling in diverse tissues |
| PRKAR2B | Type II regulatory subunit beta; interacts with CREB | Immune regulation and T cell activation |
| PRKACA | Catalytic subunit alpha; released upon cAMP binding | Mutations in Cushing's syndrome |
| PRKACB | Catalytic subunit beta; alternative catalytic isoform | Tissue-specific PKA functions |
| AKAP1 | Mitochondrial AKAP; binds regulatory subunits | Mitochondrial PKA signaling |
| AKAP5 | Postsynaptic AKAP; binds PRKAR2B | Synaptic plasticity and sleep |
| AKAP6 | Nuclear AKAP; binds regulatory subunits | Nuclear PKA signaling |
| AKAP9 | Centrosomal AKAP; binds regulatory subunits | Cell cycle regulation |
| AKAP12 | Cytoskeletal AKAP; binds regulatory subunits | Cancer and metastasis |
| TLN1 | Talin-1; mechanically gated AKAP | Focal adhesion mechanotransduction |
| CREB1 | Transcription factor; interacts with PRKAR2B | T cell suppression and gene expression |
| PPP3CA | Calcineurin catalytic subunit; competes with PKA | Sleep-wake regulation |
| PDE4D | Phosphodiesterase; degrades cAMP | Modulates PKA activation |
| PRKAR1A (Leishmania) | Divergent regulatory subunit in Leishmania | Pathogen morphogenesis |
How Is protein kinase A regulatory subunit binding Regulated?
The binding of proteins to PKA regulatory subunits is regulated by multiple mechanisms. cAMP levels, controlled by adenylyl cyclases and phosphodiesterases, determine the conformational state of the regulatory subunit and its availability for interactions. Phosphorylation of regulatory subunits can alter their affinity for AKAPs and catalytic subunits. Competing proteins such as calcineurin can displace PKA from binding sites, as shown in postsynaptic competition that regulates sleep-wake cycles. Additionally, mechanical forces can gate the interaction between talin and PKA regulatory subunits at focal adhesions.
protein kinase A regulatory subunit binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRKAR1A | Carney complex, endocrine tumors | Knockout and point mutation cell lines |
| PRKAR2B | T cell dysfunction, autoimmunity | Knockout T cells and CREB reporter assays |
| PRKAR1B | Neurological disorders, sleep abnormalities | Knock-in mice with N3A motif variants |
| TLN1 | Cancer mechanotransduction | Point mutation at talin-PKA interface |
| Leishmania PRKAR | Leishmaniasis | Knockout parasites and morphogenesis assays |
Sleep-wake disorders
Postsynaptic competition between calcineurin and PKA for regulatory subunit binding regulates mammalian sleep-wake cycles. Disruption of this balance can lead to sleep abnormalities, highlighting the importance of GO:0034237 in neurological function.
Immune dysregulation
PRKAR2B directly interacts with and suppresses CREB transcriptional activity in activated T cells. Aberrant PKA regulatory subunit binding may contribute to autoimmune or immunodeficiency conditions.
Infectious disease
A divergent PKA regulatory subunit is essential for morphogenesis of the human pathogen Leishmania. Targeting this interaction could provide new therapeutic strategies against leishmaniasis.
Cancer and endocrine disorders
Mutations in PRKAR1A cause Carney complex, a multiple neoplasia syndrome. Altered PKA regulatory subunit binding affects cAMP signaling and cell proliferation, making it relevant to endocrine tumors [3,6].
From protein kinase A regulatory subunit binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PRKAR1A affect PKA localization? | CRISPR knockout in HEK293 or HeLa cells |
| How do N3A motif variants alter cAMP sensitivity? | Point mutation knock-in in PRKAR1B |
| Can talin mechanically gate PKA binding? | Tagged knock-in of TLN1 with force sensors |
| Does PRKAR2B suppress CREB in T cells? | Overexpression and knockout in Jurkat T cells |
| Is the Leishmania regulatory subunit essential? | CRISPR knockout in Leishmania |
| How does calcineurin compete with PKA at synapses? | Knockout and knock-in mouse models |
How to Study the protein kinase A regulatory subunit binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Physical interaction between regulatory subunit and partners | Validation of AKAP binding |
| FRET biosensors | Real-time cAMP and PKA activity | Live-cell imaging of signaling dynamics |
| CRISPR knockout screens | Genes required for PKA regulatory subunit binding | Discovery of novel pathway components |
| X-ray crystallography | Atomic structure of regulatory subunit complexes | Mechanistic understanding of cAMP binding |
| Phosphoproteomics | Downstream phosphorylation events | Mapping PKA substrate networks |
| RNA-seq | Transcriptional changes upon PKA modulation | CREB target gene analysis |
| Surface plasmon resonance | Binding affinity and kinetics | Quantifying AKAP-regulatory subunit interactions |
| Proximity ligation assay | In situ interaction detection | Localization of PKA-regulatory subunit complexes |
Affinity purification and mass spectrometry
Affinity purification of PKA regulatory subunits followed by mass spectrometry can identify novel binding partners and map interaction interfaces. This approach has been used to characterize AKAPs and other proteins that bind to PRKAR1A and PRKAR2A [3,4].
FRET and biosensor imaging
Genetically encoded FRET biosensors can monitor cAMP dynamics and PKA regulatory subunit binding in live cells. These tools reveal spatiotemporal patterns of PKA activation and anchoring.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes that modulate PKA regulatory subunit binding and downstream signaling. Such screens are valuable for discovering new components of the pathway.
Structural biology
X-ray crystallography and cryo-EM have elucidated the structure of PKA regulatory subunits with cAMP and catalytic subunits. These studies provide a framework for understanding disease mutations.
How CRISPR Can Be Used to Study GO:0034237 protein kinase A regulatory subunit binding
Knockout
CRISPR knockout of PRKAR1A, PRKAR2A, or AKAP genes can abolish specific PKA regulatory subunit binding events, revealing their roles in cAMP signaling and disease. For example, knockout of PRKAR2B in T cells can test its role in CREB suppression.
Point Mutation
Introducing point mutations in the N3A motif of PRKAR1B or in the AKAP-binding domain of regulatory subunits can dissect isoform-specific functions and disease-associated variants.
Knock-in
Tagged knock-in of regulatory subunits (e.g., GFP or HaloTag) allows live-cell imaging of PKA localization and binding dynamics. Knock-in of disease mutations can model their effects on PKA signaling.
Overexpression
Overexpression of wild-type or mutant regulatory subunits can test dominant-negative effects and interactions with AKAPs or CREB. This approach is useful for studying gain-of-function mutations.
How EDITGENE Supports protein kinase A regulatory subunit binding Research
Researchers studying protein kinase A regulatory subunit binding-related genes often need to determine whether a candidate gene is causally involved in PKA anchoring, cAMP sensing, or downstream signaling. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for protein kinase A regulatory subunit binding research.
Frequently Asked Questions About protein kinase A regulatory subunit binding
What is protein kinase A regulatory subunit binding?
It is the molecular function defined by GO:0034237, describing the binding of a protein to one or both regulatory subunits of PKA, which can anchor or modulate the kinase.
What genes are involved in protein kinase A regulatory subunit binding?
Key genes include PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B, and AKAPs such as TLN1, AKAP5, and AKAP9 [3,4,5].
How does cAMP affect PKA regulatory subunit binding?
cAMP binds to the regulatory subunit, causing a conformational change that releases the catalytic subunit and modulates interactions with AKAPs.
What diseases are associated with PKA regulatory subunit binding?
Diseases include Carney complex, sleep-wake disorders, immune dysregulation, and Leishmaniasis [1,2,3,8].
What is the role of AKAPs in PKA regulatory subunit binding?
AKAPs bind to the dimerization/docking domain of regulatory subunits to anchor PKA to specific subcellular locations.
How can CRISPR be used to study PKA regulatory subunit binding?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of regulatory subunit interactions [5,6].
What is the structure of PKA regulatory subunits?
They contain a dimerization/docking domain and two cAMP-binding domains; structures have been solved by X-ray crystallography.
How is PKA regulatory subunit binding regulated?
It is regulated by cAMP levels, phosphorylation, competing proteins like calcineurin, and mechanical forces [2,3,4].
What methods are used to study PKA regulatory subunit binding?
Methods include co-immunoprecipitation, FRET biosensors, CRISPR screens, and structural biology [4,6,7].
Why is GO:0034237 important for drug discovery?
It represents a hub for signaling specificity; targeting these interactions could modulate PKA in diseases like cancer and autoimmunity [3,6].
Conclusion
GO:0034237, protein kinase A regulatory subunit binding, is a central molecular function that governs PKA localization, activity, and signaling specificity. Through interactions with regulatory subunits and AKAPs, it influences diverse physiological processes and is implicated in diseases ranging from sleep disorders to cancer. CRISPR-based models and advanced proteomic methods are essential to further dissect this function. EDITGENE offers comprehensive services to support such research, from knockout and point mutation models to library screening and bioinformatics.
References
- 1. Fischer Weinberger R et al.. 2024. A divergent protein kinase A regulatory subunit essential for morphogenesis of the human pathogen Leishmania.. PLoS Pathog 20(3):e1012073 PMID: 38551993
- 2. Wang Y et al.. 2024. Postsynaptic competition between calcineurin and PKA regulates mammalian sleep-wake cycles.. Nature 636(8042):412-421 PMID: 39506111
- 3. Taylor SS et al.. 2022. The Tails of Protein Kinase A.. Mol Pharmacol 101(4):219-225 PMID: 34330820
- 4. Kang M et al.. 2024. The focal adhesion protein talin is a mechanically gated A-kinase anchoring protein.. Proc Natl Acad Sci U S A 121(13):e2314947121 PMID: 38513099
- 5. Wallbott M et al.. 2026. Functional divergence of protein kinase A regulatory subunit Iβ variants: the importance of N3A motifs in PKA regulation.. FEBS J 293(8):2417-2434 PMID: 41388753
- 6. Turnham RE et al.. 2016. Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology.. Gene 577(2):101-8 PMID: 26687711
- 7. Su Y et al.. 1995. Regulatory subunit of protein kinase A: structure of deletion mutant with cAMP binding domains.. Science 269(5225):807-13 PMID: 7638597
- 8. Elliott MR et al.. 2003. Protein kinase A regulatory subunit type II beta directly interacts with and suppresses CREB transcriptional activity in activated T cells.. J Immunol 171(7):3636-44 PMID: 14500661
